US Bancorp
REPL icon

US Bancorp’s Replimune Group REPL Stock Holding History

US Bancorp’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.5K Buy
3,339
+200
+6% +$1.53K ﹤0.01% 3000
2025
Q4 		$30.5K Buy
3,139
+294
+10% +$2.5K ﹤0.01% 2907
2025
Q3 		$11.9K Sell
2,845
-3,127
-52% -$20K ﹤0.01% 3259
2025
Q2 		$55.5K Buy
5,972
+1,378
+30% +$12K ﹤0.01% 2734
2025
Q1 		$44.8K Buy
4,594
+3,921
+583% +$48.5K ﹤0.01% 2806
2024
Q4 		$8.15K Buy
673
+21
+3% +$255 ﹤0.01% 3490
2024
Q3 		$7.15K Sell
652
-129
-17% -$1.31K ﹤0.01% 3467
2024
Q2 		$7.03K Buy
781
+491
+169% +$3.42K ﹤0.01% 3420
2024
Q1 		$2.37K Buy
290
+180
+164% +$1.48K ﹤0.01% 3695
2023
Q4 		$927 Sell
110
-114
-51% -$1.32K ﹤0.01% 3808
2023
Q3 		$3.83K Sell
224
-19,653
-99% -$386K ﹤0.01% 3510
2023
Q2 		$462K Buy
19,877
+1,779
+10% +$34.8K ﹤0.01% 1446
2023
Q1 		$320K Sell
18,098
-705
-4% -$16.8K ﹤0.01% 1648
2022
Q4 		$511K Buy
18,803
+17,990
+2,213% +$374K ﹤0.01% 1388
2022
Q3 		$14K Sell
813
-159
-16% -$3.03K ﹤0.01% 3234
2022
Q2 		$17K Buy
+972
New +$16K ﹤0.01% 3145
2021
Q1 		– Sell
-245
Closed -$9K – 3951
2020
Q4 		$9K Buy
+245
New +$10.2K ﹤0.01% 3233

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

US Bancorp's REPL Position: Q1 2026 in Review

US Bancorp increased its Replimune Group (REPL) stake by 6.4% in Q1 2026, buying an estimated $1.53K and bringing the position to 3,339 shares worth $25.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3000.

US Bancorp first reported a position in REPL in Q4 2020 and has held it in 17 quarters since. The position peaked at $511K in Q4 2022. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • US Bancorp held 3,339 shares of Replimune Group worth $25.5K as of Q1 2026.
  • US Bancorp bought 200 Replimune Group shares in Q1 2026, an estimated $1.53K.
  • Replimune Group made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #3000 holding.
  • US Bancorp first reported a position in Replimune Group in Q4 2020 and has held it in 17 quarters since.
  • US Bancorp's Replimune Group position peaked at $511K in Q4 2022.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.